Chemotherapy plus bevacizumab as an optimal first-line therapeutic treatment for patients with right-sided metastatic colon cancer: a meta-analysis of first-line clinical trials

• Xia-Hong You,
• Yu-Huan Jiang,
• Zhou Fang,
• Yao Li,
• Zi-Jin Xia,
• Xiao-Zhong Wang,
• Hou-Qun Ying

Affiliations

Xia-Hong You

Department of Clinical Laboratory, Jiangxi Province Key Laboratory of Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

Yu-Huan Jiang

Department of Clinical Laboratory, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

Zhou Fang

Department of Laboratory Medicine, Nanchang University Medical College, Nanchang, Jiangxi, China

Yao Li

Department of Laboratory Medicine, Nanchang University Medical College, Nanchang, Jiangxi, China

Zi-Jin Xia

Department of Laboratory Medicine, Nanchang University Medical College, Nanchang, Jiangxi, China

Xiao-Zhong Wang

Department of Clinical Laboratory, Jiangxi Province Key Laboratory of Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

Hou-Qun Ying

Department of Clinical Laboratory, Jiangxi Province Key Laboratory of Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China